Delivery Order SPE2DB22D2206-SPE2DB23FHY22
Award Date 6/29/23
Potential Completion Date 7/21/23
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for 84 tablets of Xermelo 250 mg on July 23, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement fulfilling pharmaceutical supply requirements for military healthcare systems. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xermelo 250 mg tablets (84-count units) with a ceiling value of $5,526.76. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xermelo 250 mg tablets (84-count). This firm fixed-price delivery order, valued at $5,526.76, represents a non-set-aside competitive award with an ultimate completion date of September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for Xermelo 250 mg tablets (84-count supply) on August 14, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xermelo 250 mg tablets (84-count) on September 9, 2025, with a ceiling value of $11,053.54 and an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 11, 2025, for the supply of Xermelo 250 mg tablets (84-count units) under a firm fixed-price contract with a ceiling value of $11,053.54. The order is expected to be completed by October 2, 2025, and will be fulfilled from the vendor's corporate office in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $9,295.70 by the Defense Logistics Agency (DLA) Troop Support Medical to supply 84 boxes of XERMELO 250 MG tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with delivery by December 13, 2023. No set-aside designation was applied to this order, which was issued against an existing DLA contract vehicle to support the agency's provision of pharmaceuticals...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization, to provide the pharmaceutical product XERMELO 250 MG TABLET 84S. The contract, valued at $19,160.74, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this order. The contract is not associated with a larger vehicle and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,775.56 Firm Fixed Price Delivery Order is for the provision of 4566736117 XERMELO 250 MG TABLET 84S, a specialty medication. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XERMELO 250 MG TABLET 84S. The contract has a firm fixed price of $5,526.76 and a period of performance through July 23, 2025. This contract is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides...